Cresilon Receives Innovative Technology Contract from Vizient for TRAUMAGEL
PR Newswire —
Contract awarded for products that bring improvement to healthcare industry NEW YORK, March 2, 2026 /PRNewswire/ -- Cresilon announced its revolutionary hemostatic gel TRAUMAGEL® has received an Innovative Technology contract from Vizient® the nation's largest provider-driven healthcare...